Skip to Main Content
OUTSOURCE EVERYTHING BUT THE GENIUS™

Go to Main Navigation

1516591352216 Elizabeth Tanner

Elizabeth Tanner is a freelance medical writer.
Showing 1 - 10 of 16 posts
Jan 2, 2014

At Scientist, we discuss the latest trends in drug development, techniques, and the pharmaceutical industry. Here are the top posts from 2013...

Dec 31, 2013

The need for CNS therapeutics is on the rise. Neurological diseases are expected to increase steadily in the coming years. Previously, we addressed...

Dec 27, 2013

More than $2 trillion dollars a year are spent on treatments for CNS disorders. One in three people over 80 currently has Alzheimer’s disease. With...

Dec 19, 2013

The BRAIN Initiative sponsored by the NIH has pushed neuroscience and technology to center stage with President Obama supporting advancing...

Dec 10, 2013

Is there a way to quantify early drug discovery productivity to improve pharmaceutical innovation? Pharmaceutical innovation is dependent upon a...

Dec 5, 2013

Stem cells are being used to develop robust, reliable disease models that are advancing our understanding of underlying disease progression and...

Dec 3, 2013

How are stem cells advancing compound screening and analysis of drug-like properties? Stem cells are emerging as significant reagents in drug...

Nov 20, 2013

Advances in Culturing Stem Cells Stem cells may hold the answer to one of the biggest medical challenges, replacing tissues and organs. Exciting...

Nov 14, 2013

Development of clinical diagnostics is a major target for pharmaceutical companies. Drug development is facing new challenges as it becomes more...